Advertisement
Canada markets closed
  • S&P/TSX

    23,956.82
    -77.01 (-0.32%)
     
  • S&P 500

    5,738.17
    -7.20 (-0.13%)
     
  • DOW

    42,313.00
    +137.89 (+0.33%)
     
  • CAD/USD

    0.7401
    -0.0025 (-0.33%)
     
  • CRUDE OIL

    68.64
    +0.97 (+1.43%)
     
  • Bitcoin CAD

    89,347.87
    +950.26 (+1.07%)
     
  • XRP CAD

    0.80
    +0.00 (+0.47%)
     
  • GOLD FUTURES

    2,680.80
    -14.10 (-0.52%)
     
  • RUSSELL 2000

    2,224.70
    +14.83 (+0.67%)
     
  • 10-Yr Bond

    3.7490
    -0.0420 (-1.11%)
     
  • NASDAQ

    18,119.59
    -70.70 (-0.39%)
     
  • VOLATILITY

    16.96
    +1.59 (+10.34%)
     
  • FTSE

    8,320.76
    +35.85 (+0.43%)
     
  • NIKKEI 225

    39,829.56
    +903.93 (+2.32%)
     
  • CAD/EUR

    0.6625
    -0.0016 (-0.24%)
     

Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 50% Undervaluation?

Key Insights

  • Option Care Health's estimated fair value is US$64.18 based on 2 Stage Free Cash Flow to Equity

  • Option Care Health is estimated to be 50% undervalued based on current share price of US$32.37

  • Analyst price target for OPCH is US$39.25 which is 39% below our fair value estimate

In this article we are going to estimate the intrinsic value of Option Care Health, Inc. (NASDAQ:OPCH) by taking the expected future cash flows and discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example!

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

See our latest analysis for Option Care Health

The Calculation

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:

10-year free cash flow (FCF) forecast

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

Levered FCF ($, Millions)

US$280.0m

US$316.0m

US$343.0m

US$366.1m

US$386.1m

US$403.7m

US$419.7m

US$434.4m

US$448.4m

US$461.8m

Growth Rate Estimate Source

Analyst x3

Analyst x1

Est @ 8.54%

Est @ 6.73%

Est @ 5.46%

Est @ 4.57%

Est @ 3.95%

Est @ 3.52%

Est @ 3.21%

Est @ 3.00%

Present Value ($, Millions) Discounted @ 5.8%

US$265

US$282

US$290

US$292

US$291

US$288

US$283

US$277

US$270

US$263

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$2.8b

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.5%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 5.8%.

Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = US$462m× (1 + 2.5%) ÷ (5.8%– 2.5%) = US$14b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$14b÷ ( 1 + 5.8%)10= US$8.2b

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$11b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of US$32.4, the company appears quite undervalued at a 50% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

dcf
dcf

The Assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Option Care Health as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Option Care Health

Strength

  • Debt is well covered by earnings and cashflows.

Weakness

  • Earnings declined over the past year.

Opportunity

  • Annual revenue is forecast to grow faster than the American market.

  • Good value based on P/E ratio and estimated fair value.

Threat

  • Annual earnings are forecast to grow slower than the American market.

Looking Ahead:

Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For Option Care Health, we've put together three additional aspects you should assess:

  1. Risks: Take risks, for example - Option Care Health has 2 warning signs we think you should be aware of.

  2. Future Earnings: How does OPCH's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.